Gillian Bubb

Senior Director Clinical Science, Clinical Development. Rare Genetic Disease at Aeglea BioTherapeutics

Gillian Bubb has extensive experience in clinical development, working at companies such as Aeglea BioTherapeutics, Alexion Pharmaceuticals, Synageva BioPharma Corp., Quintiles, and AstraZeneca. Gillian has held various roles such as Clinical Study Leader, Clinical Research Manager, and Senior Clinical Research Associate. Gillian holds a PhD in Biology from the University of Warwick.

Location

Leicester, United Kingdom

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Aeglea BioTherapeutics

Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.


Industries

Employees

51-200

Links